Célio Roberto Gonçalves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Célio Roberto Gonçalves has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Percival Degrava Sampaio-Barros
Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
5 shared publications Andrea Lopes Gallinaro
Universidade Federal de São Paulo
4 shared publicationsAndréa Lopes Gallinaro
2 shared publicationsCamila Ventura
2 shared publications- Carla Gonçalves Schahin Saad
Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
2 shared publications - Carlos Ewerton Maia Rodrigues
Graduate Program in Medical Sciences, Universidade de Fortaleza (Unifor), Fortaleza, Brazil
2 shared publications
Latest Publications
- 31 December 2020
- Published by Revista Paulista de Reumatologia in Revista Paulista de Reumatologia
- No. 2020 out-d
Exames complementares das entesopatias. Parte 2 – Imagem: radiografia convencional
A radiografia convencional é o método de imagem mais acessível, seja pelo menor custo, seja pela maior disponibilidade. Não apresenta alta sensibilidade ou especificidade, de forma geral é útil no contexto clínico para avaliação das artropatias e do dano estrutural das entesopatias, em particular na avaliação do processo de neoformação óssea pós-inflamatória das ênteses. A ossificação das ênteses ocorre como processo de reparo em reação a uma inflamação prévia que ocorreu de maneira geral alguns meses antes do aparecimento do achado radiográfico, conforme descrito nos artigos “Êntese – Uma R(E)volução” e “Fisiopatologia das entesopatias: aspectos mecânicos e inflamatórios (axial e periférico)” desta revista. Portanto, os achados da radiografia convencional não demostram o processo inflamatório atual, mas sim a sequela e reparo de um processo pregresso. Os locais mais comumente afetados podem ser avaliados pela radiografia, sendo por óbvio os locais onde temos ênteses mais submetidas a estresse mecânico e inflamatório. Quando as articulações periféricas são acometidas, radiografias das mãos e dos pés são úteis para este tipo de avaliação. Os sítios mais comumente pesquisados são calcâneos, ombros, joelhos e bacia. A avaliação das ênteses na região das articulações da coluna vertebral pode corroborar no diagnóstico destas enfermidades. Os padrões de calcificação ou neoformação óssea podem ser úteis na diferenciação das entesopatias. Calcificações com padrão de “tração”, delgadas e lineares, sem perda do contorno anatômico, ou depósitos difusos e calcificações tendíneas, ou com formações “em escamas” e associados a erosões, respectivamente sugestivos de processo mecânico-degenerativo, doenças por depósito e inflamação propriamente dita. Outro ponto a ser considerado na avaliação destes pacientes são possíveis variações anatômicas que acarretam alterações biomecânicas e por consequência podem afetar o padrão e a frequência de aparecimento das alterações radiográficas nas ênteses, como por exemplo, pé cavo, pé plano, escolioses, dismetria dos membros, entre outras. Adicionalmente, com o envelhecimento, ocorre naturalmente degeneração nas ênteses dos tendões, ligamentos e fáscias que se apresentam como proliferação óssea frequentemente identificadas nas radiografias, sem relação obrigatória com manifestação clínica. Em resumo, as radiografias convencionais são úteis no raciocínio diagnóstico das entesopatias, com atenção às características clínicas, anatômicas e funcionais dos indivíduos. Unitermos: Entesopatia. Entesite. Radiografia convencional. Calcificações.
- 31 December 2020
- Published by Revista Paulista de Reumatologia in Revista Paulista de Reumatologia
- No. 2020 out-d
Exames complementares das entesopatias. Parte 2 – Imagem: radiografia convencional
A radiografia convencional é o método de imagem mais acessível, seja pelo menor custo, seja pela maior disponibilidade. Não apresenta alta sensibilidade ou especificidade, de forma geral é útil no contexto clínico para avaliação das artropatias e do dano estrutural das entesopatias, em particular na avaliação do processo de neoformação óssea pós-inflamatória das ênteses. A ossificação das ênteses ocorre como processo de reparo em reação a uma inflamação prévia que ocorreu de maneira geral alguns meses antes do aparecimento do achado radiográfico, conforme descrito nos artigos “Êntese – Uma R(E)volução” e “Fisiopatologia das entesopatias: aspectos mecânicos e inflamatórios (axial e periférico)” desta revista. Portanto, os achados da radiografia convencional não demostram o processo inflamatório atual, mas sim a sequela e reparo de um processo pregresso. Os locais mais comumente afetados podem ser avaliados pela radiografia, sendo por óbvio os locais onde temos ênteses mais submetidas a estresse mecânico e inflamatório. Quando as articulações periféricas são acometidas, radiografias das mãos e dos pés são úteis para este tipo de avaliação. Os sítios mais comumente pesquisados são calcâneos, ombros, joelhos e bacia. A avaliação das ênteses na região das articulações da coluna vertebral pode corroborar no diagnóstico destas enfermidades. Os padrões de calcificação ou neoformação óssea podem ser úteis na diferenciação das entesopatias. Calcificações com padrão de “tração”, delgadas e lineares, sem perda do contorno anatômico, ou depósitos difusos e calcificações tendíneas, ou com formações “em escamas” e associados a erosões, respectivamente sugestivos de processo mecânico-degenerativo, doenças por depósito e inflamação propriamente dita. Outro ponto a ser considerado na avaliação destes pacientes são possíveis variações anatômicas que acarretam alterações biomecânicas e por consequência podem afetar o padrão e a frequência de aparecimento das alterações radiográficas nas ênteses, como por exemplo, pé cavo, pé plano, escolioses, dismetria dos membros, entre outras. Adicionalmente, com o envelhecimento, ocorre naturalmente degeneração nas ênteses dos tendões, ligamentos e fáscias que se apresentam como proliferação óssea frequentemente identificadas nas radiografias, sem relação obrigatória com manifestação clínica. Em resumo, as radiografias convencionais são úteis no raciocínio diagnóstico das entesopatias, com atenção às características clínicas, anatômicas e funcionais dos indivíduos. Unitermos: Entesopatia. Entesite. Radiografia convencional. Calcificações.
- Open Access
- 24 February 2016
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 18 (1) , 52
IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients
Advances in pathophysiology and treatment of ankylosing spondylitis (AS) was recently demonstrated. However, the effect of anti-TNF in the newly described inflammatory pathways involved pathogenesis of this disease remains to be determined. The aim of our study was, therefore, to investigate long-term influence of anti-TNF drugs in IL-23/IL-17 axis of AS patients and their possible correlation with treatment, clinical, laboratory and radiographic parameters. Eighty-six AS anti-TNF naïve patients, 47 referred for anti-TNF therapy (active-AS; BASDAI ≥ 4) and 39 with BASDAI < 4 (control-AS) were included. The active group was evaluated at baseline, 12-months and 24-months after TNF blockade and compared at baseline to control-AS group and to 47 healthy age- and gender-matched controls. Plasma levels of IL-17A, IL-22, IL-23 and PGE2 were measured. Non-steroidal anti-inflammatory drugs (NSAIDs) intake were recorded every 6 months. Radiographic severity and progression was assessed by mSASSS at baseline and 24 months after therapy. At baseline, active-AS group presented higher IL-23 and PGE2 levels compared to control-AS group (p < 0.001 and p = 0.008) and to healthy controls (p < 0.001 and p = 0.02). After 24-months of TNF blockade, IL-23 and PGE2 remained elevated with higher levels compared with the healthy group (p < 0.001 and p = 0.03) in spite of significant improvements in all clinical/inflammatory parameters (p < 0.001). Further analysis of 27 anti-TNF-treated patients who achieved a good response (ASDAS-CRP < 2.1,with a drop ≥ 1.1) at 24-months revealed that IL-23 plasma levels remained higher than healthy controls (p < 0.001) and higher than control-AS group with similar disease activity (ASDAS-CRP < 2.1, p = 0.01). In active-AS group (n = 47), there was a strong correlation between IL-23 and IL-17A at baseline, 12-months and 24-months after anti-TNF therapy (p ≤ 0.001). This study provides novel data demonstrating that the IL-23/IL-17 axis is not influenced by TNF blockade in AS patients despite clinical and inflammation improvements and NSAID intake.
- 24 February 2016
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 18 (1) , 52
Open AccessIL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients
Advances in pathophysiology and treatment of ankylosing spondylitis (AS) was recently demonstrated. However, the effect of anti-TNF in the newly described inflammatory pathways involved pathogenesis of this disease remains to be determined. The aim of our study was, therefore, to investigate long-term influence of anti-TNF drugs in IL-23/IL-17 axis of AS patients and their possible correlation with treatment, clinical, laboratory and radiographic parameters. Eighty-six AS anti-TNF naïve patients, 47 referred for anti-TNF therapy (active-AS; BASDAI ≥ 4) and 39 with BASDAI < 4 (control-AS) were included. The active group was evaluated at baseline, 12-months and 24-months after TNF blockade and compared at baseline to control-AS group and to 47 healthy age- and gender-matched controls. Plasma levels of IL-17A, IL-22, IL-23 and PGE2 were measured. Non-steroidal anti-inflammatory drugs (NSAIDs) intake were recorded every 6 months. Radiographic severity and progression was assessed by mSASSS at baseline and 24 months after therapy. At baseline, active-AS group presented higher IL-23 and PGE2 levels compared to control-AS group (p < 0.001 and p = 0.008) and to healthy controls (p < 0.001 and p = 0.02). After 24-months of TNF blockade, IL-23 and PGE2 remained elevated with higher levels compared with the healthy group (p < 0.001 and p = 0.03) in spite of significant improvements in all clinical/inflammatory parameters (p < 0.001). Further analysis of 27 anti-TNF-treated patients who achieved a good response (ASDAS-CRP < 2.1,with a drop ≥ 1.1) at 24-months revealed that IL-23 plasma levels remained higher than healthy controls (p < 0.001) and higher than control-AS group with similar disease activity (ASDAS-CRP < 2.1, p = 0.01). In active-AS group (n = 47), there was a strong correlation between IL-23 and IL-17A at baseline, 12-months and 24-months after anti-TNF therapy (p ≤ 0.001). This study provides novel data demonstrating that the IL-23/IL-17 axis is not influenced by TNF blockade in AS patients despite clinical and inflammation improvements and NSAID intake.
- 1 December 2012
- Vol. 52 (6) , 887-91
Sexual activity in ankylosing spondylitis.
To assess the sexual activity of patients with ankylosing spondylitis, correlating it with disease activity and functional indices. Thirty-two patients with ankylosing spondylitis and 32 healthy controls were assessed regarding pain, fatigue, sexual activity (by use of pictures of seven sexual positions), disease activity (by use of Bath Ankylosing Spondylitis Disease Activity Index - BASDAI), and functional capacity (by use of Bath Ankylosing Spondylitis Functional Index - BASFI). After the interview, the patients were divided into two groups: group A (with sexual activity) and group B (no sexual activity). Group B showed statistical association with longer disease duration (P = 0.01), and higher BASFI (P = 0.0007) and BASDAI (P = 0.03) scores. No correlation was observed between age and functional capacity. Man lying on his back and woman on top was the most frequent, enjoyable and least painful position. The position with the woman on her back and a man lying on top was the least chosen. Control individuals reported a higher frequency of sexual activity, longer duration of intercourse, and less pain and fatigue; the reported frequency of orgasms, however, was similar in both groups. The chronic nature of ankylosing spondylitis, with poor functional capacity and higher disease activity, interferes with sexual intercourse. When sexual activity was possible, orgasm and sexual satisfaction did not differ from those of healthy controls.
- 1 December 2012
- Vol. 52 (6) , 887-91
Sexual activity in ankylosing spondylitis.
To assess the sexual activity of patients with ankylosing spondylitis, correlating it with disease activity and functional indices. Thirty-two patients with ankylosing spondylitis and 32 healthy controls were assessed regarding pain, fatigue, sexual activity (by use of pictures of seven sexual positions), disease activity (by use of Bath Ankylosing Spondylitis Disease Activity Index - BASDAI), and functional capacity (by use of Bath Ankylosing Spondylitis Functional Index - BASFI). After the interview, the patients were divided into two groups: group A (with sexual activity) and group B (no sexual activity). Group B showed statistical association with longer disease duration (P = 0.01), and higher BASFI (P = 0.0007) and BASDAI (P = 0.03) scores. No correlation was observed between age and functional capacity. Man lying on his back and woman on top was the most frequent, enjoyable and least painful position. The position with the woman on her back and a man lying on top was the least chosen. Control individuals reported a higher frequency of sexual activity, longer duration of intercourse, and less pain and fatigue; the reported frequency of orgasms, however, was similar in both groups. The chronic nature of ankylosing spondylitis, with poor functional capacity and higher disease activity, interferes with sexual intercourse. When sexual activity was possible, orgasm and sexual satisfaction did not differ from those of healthy controls.
- Open Access
- 1 December 2012
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 52 (6) , 887-891
Atividade sexual na espondilite anquilosante
- 1 December 2012
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 52 (6) , 887-891
Open AccessAtividade sexual na espondilite anquilosante
- Open Access
- 12 October 2012
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 14 (5) , R216
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Introduction: Sclerostin levels have been reported to be low in ankylosing spondylitis (AS), but there is no data regarding the possible role of this Wnt inhibitor during anti-tumor necrosis factor (TNF) therapy. The present study longitudinally evaluated sclerostin levels, inflammatory markers and bone mineral density (BMD) in AS patients under anti-TNF therapy. Methods: Thirty active AS patients were assessed at baseline, 6 and 12 months after anti-TNF therapy regarding clinical parameters, inflammatory markers, BMD and baseline radiographic damage (mSASSS). Thirty age- and sex-matched healthy individuals comprised the control group. Patients' sclerostin levels, sclerostin binding low-density lipoprotein receptor-related protein 6 (LRP6) and BMD were evaluated at the same time points and compared to controls. Results: At baseline, AS patients had lower sclerostin levels (60.5 ± 32.7 vs. 96.7 ± 52.9 pmol/L, P = 0.002) and comparable sclerostin binding to LRP6 (P = 0.387) than controls. Improvement of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Ankylosing Spondylitis quality of life (ASQoL) was observed at baseline vs. 6 vs. 12 months (P < 0.01). Concomitantly, a gradual increase in spine BMD (P < 0.001) and a positive correlation between baseline mSASSS and spine BMD was found (r = 0.468, P < 0.01). Inflammatory parameters reduction was observed comparing baseline vs. 6 vs. 12 months (P < 0.01). Sclerostin levels progressively increased [baseline (60.5 ± 32.7) vs. 6 months (67.1 ± 31.9) vs. 12 months (72.7 ± 32.3) pmol/L, P < 0.001]. At 12 months, the sclerostin levels remained significantly lower in patients compared to controls (72.7 ± 32.3 vs. 96.70 ± 52.85 pmol/L, P = 0.038). Moreover, sclerostin serum levels at 12 months were lower in the 10 patients with high C reactive protein (CRP) (≥ 5 mg/l) compared to the other 20 patients with normal CRP (P = 0.004). Of note, these 10 patients with persistent inflammation also had lower sclerostin serum levels at baseline compared to the other patients (P = 0.023). Univariate logistic regression analysis demonstrated that AS patients with lower sclerostin serum levels had an increased risk to have high CRP at 12 months (odds ratio = 7.43, 95% CI 1.23 to 45.01, P = 0.020) than those with higher sclerostin values. Conclusions: Persistent low sclerostin levels may underlie continuous inflammation in AS patients under anti-TNF therapy.
- 12 October 2012
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 14 (5) , R216
Open AccessLow sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Introduction: Sclerostin levels have been reported to be low in ankylosing spondylitis (AS), but there is no data regarding the possible role of this Wnt inhibitor during anti-tumor necrosis factor (TNF) therapy. The present study longitudinally evaluated sclerostin levels, inflammatory markers and bone mineral density (BMD) in AS patients under anti-TNF therapy. Methods: Thirty active AS patients were assessed at baseline, 6 and 12 months after anti-TNF therapy regarding clinical parameters, inflammatory markers, BMD and baseline radiographic damage (mSASSS). Thirty age- and sex-matched healthy individuals comprised the control group. Patients' sclerostin levels, sclerostin binding low-density lipoprotein receptor-related protein 6 (LRP6) and BMD were evaluated at the same time points and compared to controls. Results: At baseline, AS patients had lower sclerostin levels (60.5 ± 32.7 vs. 96.7 ± 52.9 pmol/L, P = 0.002) and comparable sclerostin binding to LRP6 (P = 0.387) than controls. Improvement of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Ankylosing Spondylitis quality of life (ASQoL) was observed at baseline vs. 6 vs. 12 months (P < 0.01). Concomitantly, a gradual increase in spine BMD (P < 0.001) and a positive correlation between baseline mSASSS and spine BMD was found (r = 0.468, P < 0.01). Inflammatory parameters reduction was observed comparing baseline vs. 6 vs. 12 months (P < 0.01). Sclerostin levels progressively increased [baseline (60.5 ± 32.7) vs. 6 months (67.1 ± 31.9) vs. 12 months (72.7 ± 32.3) pmol/L, P < 0.001]. At 12 months, the sclerostin levels remained significantly lower in patients compared to controls (72.7 ± 32.3 vs. 96.70 ± 52.85 pmol/L, P = 0.038). Moreover, sclerostin serum levels at 12 months were lower in the 10 patients with high C reactive protein (CRP) (≥ 5 mg/l) compared to the other 20 patients with normal CRP (P = 0.004). Of note, these 10 patients with persistent inflammation also had lower sclerostin serum levels at baseline compared to the other patients (P = 0.023). Univariate logistic regression analysis demonstrated that AS patients with lower sclerostin serum levels had an increased risk to have high CRP at 12 months (odds ratio = 7.43, 95% CI 1.23 to 45.01, P = 0.020) than those with higher sclerostin values. Conclusions: Persistent low sclerostin levels may underlie continuous inflammation in AS patients under anti-TNF therapy.
- 1 October 2012
- Vol. 52 (5) , 733-41
Cross-cultural adaptation and validation of the Brazilian-Portuguese version of the Bath Ankylosing Spondylitis Functional Index (BASFI).
To conduct a cross-cultural adaptation of the Bath Ankylosing Spondylitis Functional Index (BASFI) into Brazilian-Portuguese language and to assess its measurement properties. The BASFI was translated by four rheumatologists and three English teachers. The translated questionnaire was applied to ankylosing spondylitis patients by trained observers, and self-administered in three moments: days 1, 2, and 14. The validity was assessed analyzing the association of BASFI and functional capacity measures (cervical rotation, intermalleolar distance, Schober's test and occiput-to-wall distance). The internal consistence was tested by Cronbach's α coefficient and the reliability by test-retest (intraclass correlation coefficient - ICC). A total of 60 patients with ankylosing spondylitis was included: 85% male, mean age 47 ± 12 years, and mean disease duration 20 ± 11 years. The intra-observer test-retest (two-week interval) reliability showed a high ICC (0.999, 95% CI: 0.997-0.999) and a high internal consistency (Cronbach's α coefficient: 0.86, CI 95%: 0.80-0.90). Considering the validity, the BASFI indices were correlated with cervical rotation (0.53, P < 0.001) and with intermalleolar distance (0.50, P < 0.001). The BASFI Brazilian-Portuguese version is reliable and valid for assessment of patients with ankylosing spondylitis.
- 1 October 2012
- Vol. 52 (5) , 733-41
Cross-cultural adaptation and validation of the Brazilian-Portuguese version of the Bath Ankylosing Spondylitis Functional Index (BASFI).
To conduct a cross-cultural adaptation of the Bath Ankylosing Spondylitis Functional Index (BASFI) into Brazilian-Portuguese language and to assess its measurement properties. The BASFI was translated by four rheumatologists and three English teachers. The translated questionnaire was applied to ankylosing spondylitis patients by trained observers, and self-administered in three moments: days 1, 2, and 14. The validity was assessed analyzing the association of BASFI and functional capacity measures (cervical rotation, intermalleolar distance, Schober's test and occiput-to-wall distance). The internal consistence was tested by Cronbach's α coefficient and the reliability by test-retest (intraclass correlation coefficient - ICC). A total of 60 patients with ankylosing spondylitis was included: 85% male, mean age 47 ± 12 years, and mean disease duration 20 ± 11 years. The intra-observer test-retest (two-week interval) reliability showed a high ICC (0.999, 95% CI: 0.997-0.999) and a high internal consistency (Cronbach's α coefficient: 0.86, CI 95%: 0.80-0.90). Considering the validity, the BASFI indices were correlated with cervical rotation (0.53, P < 0.001) and with intermalleolar distance (0.50, P < 0.001). The BASFI Brazilian-Portuguese version is reliable and valid for assessment of patients with ankylosing spondylitis.
- Open Access
- 1 October 2012
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 52 (5) , 737-741
Adaptação cultural cruzada e validação da versão do Índice Funcional de Espondilite Anquilosante de Bath (BASFI) para o português do Brasil
- 1 October 2012
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 52 (5) , 737-741
Open AccessAdaptação cultural cruzada e validação da versão do Índice Funcional de Espondilite Anquilosante de Bath (BASFI) para o português do Brasil
- 30 May 2012
- Vol. 52 (3) , 375-83
Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis.
To describe the extra-articular manifestations (cardiac, renal, pulmonary, and neurological), usually not related to spondyloarthritis (SpA), in a large cohort of Brazilian patients. This retrospective study analyzed 1,472 patients diagnosed with SpA and cared for at 29 health care centers distributed in the five major geographic regions in the country, participating in the Brazilian Registry of Spondyloarthritis (BRS). All patients were assessed for the prevalence of major extra-articular manifestations (cardiac, renal, pulmonary, and neurological), classified according to the diagnosis [ankylosing spondylitis (AS), psoriatic arthritis (PsA), reactive arthritis (ReA), arthritis associated with inflammatory bowel disease (IBD), undifferentiated spondyloarthritis (uSpA), and juvenile SpA], and according to the clinical presentation (axial, peripheral, mixed, and enthesitis). Of the patients with SpA assessed, 963 had AS, 271 PsA, 49 ReA, 48 arthritis associated with IBD, 98 uSpA, and 43 juvenile SpA. Cardiac involvement was reported in 44 patients (3.0%), pulmonary involvement in 19 (1.3%), renal involvement in 17 (1.2%), and neurological involvement in 13 patients (0.9%). Most patients with visceral involvement had AS or PsA, and the mixed (axial + peripheral) and/or predominantly axial clinical form. Cardiac, renal, pulmonary, and neurological extra-articular manifestations are quite infrequent in SpA, ranging from 0.9% to 3% in this large Brazilian cohort, and affected predominantly patients with AS and PsA.
- 30 May 2012
- Vol. 52 (3) , 375-83
Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis.
To describe the extra-articular manifestations (cardiac, renal, pulmonary, and neurological), usually not related to spondyloarthritis (SpA), in a large cohort of Brazilian patients. This retrospective study analyzed 1,472 patients diagnosed with SpA and cared for at 29 health care centers distributed in the five major geographic regions in the country, participating in the Brazilian Registry of Spondyloarthritis (BRS). All patients were assessed for the prevalence of major extra-articular manifestations (cardiac, renal, pulmonary, and neurological), classified according to the diagnosis [ankylosing spondylitis (AS), psoriatic arthritis (PsA), reactive arthritis (ReA), arthritis associated with inflammatory bowel disease (IBD), undifferentiated spondyloarthritis (uSpA), and juvenile SpA], and according to the clinical presentation (axial, peripheral, mixed, and enthesitis). Of the patients with SpA assessed, 963 had AS, 271 PsA, 49 ReA, 48 arthritis associated with IBD, 98 uSpA, and 43 juvenile SpA. Cardiac involvement was reported in 44 patients (3.0%), pulmonary involvement in 19 (1.3%), renal involvement in 17 (1.2%), and neurological involvement in 13 patients (0.9%). Most patients with visceral involvement had AS or PsA, and the mixed (axial + peripheral) and/or predominantly axial clinical form. Cardiac, renal, pulmonary, and neurological extra-articular manifestations are quite infrequent in SpA, ranging from 0.9% to 3% in this large Brazilian cohort, and affected predominantly patients with AS and PsA.
- 3 December 2010
- Vol. 50 (5) , 581-9
Spondyloarthritis: analysis of a Brazilian series compared with a large Ibero-American registry (RESPONDIA group).
Recent studies have outlined the clinical and epidemiological profile of the spondyloarthritides in Ibero-American countries. The objective of this study was to compare the data collected in a Brazilian epidemiological study with the data obtained from other Ibero-American countries that used the same protocol of investigation. The Brazilian series presented a higher frequency of patients with ankylosing spondylitis (72.3% Brazilian vs. 57.7% Ibero-American), being associated with the male gender (73.6% vs. 66.0%) and histocompatibility antigen positive HLA-B27 (65.9% vs. 51.8%). Regarding the treatment, hormonal anti-inflammatory drugs - NSAIDS were more frequently prescribed to Brazilian patients (77.0% vs. 71.2%) and less often, corticosteroids (7.5% vs. 18.5%).
- 3 December 2010
- Vol. 50 (5) , 581-9
Spondyloarthritis: analysis of a Brazilian series compared with a large Ibero-American registry (RESPONDIA group).
Recent studies have outlined the clinical and epidemiological profile of the spondyloarthritides in Ibero-American countries. The objective of this study was to compare the data collected in a Brazilian epidemiological study with the data obtained from other Ibero-American countries that used the same protocol of investigation. The Brazilian series presented a higher frequency of patients with ankylosing spondylitis (72.3% Brazilian vs. 57.7% Ibero-American), being associated with the male gender (73.6% vs. 66.0%) and histocompatibility antigen positive HLA-B27 (65.9% vs. 51.8%). Regarding the treatment, hormonal anti-inflammatory drugs - NSAIDS were more frequently prescribed to Brazilian patients (77.0% vs. 71.2%) and less often, corticosteroids (7.5% vs. 18.5%).
- Open Access
- 1 October 2010
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 50 (5) , 581-589
Espondiloartrites: análise de uma série Brasileira comparada a uma grande casuística Ibero-Americana (estudo RESPONDIA)
- 1 October 2010
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 50 (5) , 581-589
Open AccessEspondiloartrites: análise de uma série Brasileira comparada a uma grande casuística Ibero-Americana (estudo RESPONDIA)